Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan To Introduce New Quality Verification System For Generic Drugs

This article was originally published in PharmAsia News

Executive Summary

In an effort to reduce safety concerns about generic drugs and increase generic usage, Japan's Ministry of Health, Labor and Welfare will introduce a third-party verification system, in addition to the ministry's approval review. The new system will verify efficacy, and confirm that generics use the same active ingredients as brand products and contain no impure substances. MHLW has established a study group under the National Institute of Health Science to spearhead the system's implementation; the group's first meeting took place July 10. (Click here for more - Japanese language

You may also be interested in...



Japanese MHLW Lists 99 Generics For NHI Pricing And Coverage

TOKYO - Japan's Ministry of Health, Labor and Welfare Nov. 7 listed 99 generic drugs made from 35 composites for National Health Insurance price listing and coverage, according to an official of the ministry's Insurance Bureau Nov. 13

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel